Breakthrough Parkinson's Study Tracks Brain Activity During Daily Life

Scientists at UCSF have made a breakthrough in Parkinson's disease research by moving brain movement studies out of the lab and into patients' homes. A team led by Dr. Doris Wang implanted a novel deep brain stimulation (DBS) device that records brain activity during everyday activities, offering new hope for treating gait impairments.

The study involved four Parkinson's patients fitted with a fully implanted, wireless bidirectional DBS system. Unlike traditional lab-based experiments, this device recorded over 80 hours of neural and movement data as participants went about their daily routines at home.

The device detected unique brain patterns linked to walking, proving it could classify movement states using only neural signals. Dr. Wang called this the first successful demonstration of a fully implanted neural interface identifying specific movements in real-world settings. Current DBS treatments often fail to address gait problems, as they focus on other Parkinson's symptoms.

Since a landmark 2013 study, around eight clinical trials on adaptive DBS for gait disorders have been launched worldwide. Notable examples include the 2021 NCT04547727 trial in the USA and the ongoing 2024 NCT05931050 study in Europe. This shift from lab to home monitoring could pave the way for more tailored brain stimulation therapies.

The findings also highlighted the need for personalised treatment models. Each patient showed distinct neural signatures when walking, reinforcing the importance of adapting therapies to individual brain activity patterns.

The UCSF study marks a significant step forward in Parkinson's disease research by proving that brain activity linked to walking can be tracked in real life. With further development, this technology could lead to more effective, personalised DBS treatments for gait impairments. The findings also support ongoing global trials exploring adaptive brain stimulation for Parkinson's patients.